Contact us today for a FREE no-obligation initial consultation

law done differently!

Category

Androgel

Feb 10
0

AndroGel Testosterone Injury Lawsuits Against AbbieVie Continue in Federal Court

By | Androgel

Androgel Testosterone Injury Lawsuits

While AbbieVie, maker of AndroGel testosterone replacement medication, landed a significant win in the ongoing Androgel testosterone injury lawsuit last month in a Chicago federal court verdict last month, the momentum in these cases is far from faltering. The Chicago Tribune reported jurors in that case ruled a 72-year-old’s pulmonary embolism could not be blamed on AbbieVie, despite evidence the drug – promoted for treatments of slipping sex drive and fatigue due to waning testosterone levels – has reportedly been associated with heart attacks, strokes and other injuries. AndroGel testosterone injury lawsuit

Although the win was a disappointment outcome, our AndroGel testosterone injury attorneys know it doesn’t mark the end of the fight, given that it’s the first victory AbbieVie has had in the cases that so far have gone to trial. The verdict comes several months after two juries in that same federal courtroom (in separate cases) sided with plaintiffs, awarding significant punitive damages ($150 million and $140 million, respectively) to men who took the drug and later suffered heart attacks.

AndroGel injury attorneys will be watching developments closely, as the federal judge in Illinois overseeing the multi-district litigation overturned one of those verdicts and granted AbbieVie’s request for a new trial, citing inconsistencies in the verdict. The new trial is scheduled for early next month. Read More

Oct 05
0

Androgel Lawsuit Update – Androgel User Awarded $140 Million

By | Androgel, Testosterone

$140 Million Awarded In 2nd Androgel User Trial

The second Androgel lawsuit has concluded with a jury in Chicago awarding Jeffrey Konrad $140 Million in punitive damages and $140,000.00 for actual damages for injuries incurred from Androgel use. Mr. Konrad suffered a heart attack after several months of Androgel use. The jury found in favor of Mr. Konrad on claims of negligence, intentional misrepresentation and misrepresentation by concealment.

The trial started on September 18, 2017 before the Honorable Matthew Kennelly. The jury started deliberation on October 3 and reached a decision on October 5 after two days of deliberation.

This is the second damaging jury decision involving Androgel and AbbVie Inc. In the Mitchell case the jury awarded $150 Million to the Androgel user. Based on the two jury decisions it appears that the marketing efforts of AbbVie Inc. is a substantial issue in Androgel Lawsuits.

Thousands of former Androgel users have alleged that their use of Androgel caused them to have heart attacks, strokes, and pulmonary embolisms. The next Androgel trial is scheduled for January, 2018.

Androgel Lawsuit Information – We Can Help Androgel Users

Many clients contact us not knowing if their heart attack, stroke, or pulmonary embolism was caused by their use of Androgel. If you are in a similar situation contact us with your questions.  If you select us to represent you we will thoroughly evaluate your case, assess the strengths and weakness and let you know the best course of action. Call us at 1-800-745-4050.

 

Top